689
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

Reply to letter by Hadigal et al. regarding the cost-effectiveness of high dose quadrivalent vaccine in three European countries

, , , , , , & show all
Pages 1167-1168 | Received 16 Jun 2023, Accepted 05 Jul 2023, Published online: 17 Jul 2023

Figures & data

This paper does not have figures.

Data availability statement

This is a letter to the Editor. Access to the original data is available as per the original article.